Notification regarding distribution of information from Diamyd Medical:

Diamyd Medical was introduced on the Nordic Exchange (former Stockholm Exchange) in 2002. Since then we have actively worked to distribute information about the company to our owners and to the public. We are pleased that you keep following the development of our Company.

As Diamyd Medical strives to make its distribution of information more effective (as well as minimizing its impact on the environment), it is proposed that all distribution of information that is made by facsimile, is transferred to e-mail. Therefore, we kindly ask you to provide us with your preferred e-mailaddress for getting future information about Diamyd Medical. Contact information is given below. Our hope is to eliminate all distribution of information via facsimile.

Kindest regards

Diamyd Medical AB (publ)

For providing an e-mailaddress:
webmaster@diamyd.com
Göran Hillborg
Mobile: +46 7 0585 3086

For questions:
Phone: +46 8 661 0026 (switchboard)
Investor.relations@diamyd.com

About Us

Mertiva AB (former Diamyd Medical) primarily consists of holdings in liquid assets and holdings in Protein Sciences Corporation and Mercodia AB. Mertiva (former Diamyd Medical) shares are listed on Nasdaq OMX (segment Small Cap) in Stockholm (ticker: DIAM B) and on OTCQX in the US (ticker: DMYDY) administered by the Pink OTC Markets and the Bank of New York Mellon (PAL).

Subscribe